StockData
Artivion, Inc. logo

Artivion, Inc. (AORT) stock

AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3021% above fair value
$19.10−0.30 (-1.55%)

Close on Nov 13, 2026Market cap $931.24MP/E –Yield –

Earnings

Artivion's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 11, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$123.80M
+9.2% on a year earlier
Adjusted diluted income per common share, non-GAAP, Q3 FY2026
$0.08
$0.16 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Artivion's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 11, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$123.80M+9.2%-$0.16$0.08Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026during market hours$125.80M+11.3%-$0.28$0.13Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours$116.30M+17.5%$0.03$0.08Release
Q4 FY2025ended Dec 31, 2025Feb 12, 2026during market hours$116.00M+19.2%$0.05$0.17Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours$113.40M+18.4%$0.13$0.16Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025during market hours$113.00M+15.3%$0.03$0.24Release
Q1 FY2025ended Mar 31, 2025May 5, 2025during market hours$99.00M+1.6%-$0.01$0.06Release
Q4 FY2024ended Dec 31, 2024Feb 24, 2025during market hours$97.30M+3.8%-$0.39$0.00Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024during market hours$95.80M+9.0%––Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024during market hours$98.00M+9.7%-$0.05$0.07Release
Q1 FY2024ended Mar 31, 2024May 6, 2024during market hours$97.40M+17.1%$0.18$0.06Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Artivion's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growth on an adjusted constant currency basisnon-GAAPFY2026+8% – +10%–NewNov 5, 2026
revenueFY2026$484.00M – $492.00M–NewNov 5, 2026
revenueFY2026$480.00M – $496.00M$480.00M – $496.00MReaffirmedAug 6, 2026
revenue growthnon-GAAPFY2026+7% – +11%+7% – +11%ReaffirmedAug 6, 2026
adjusted EBITDAnon-GAAPFY2026$93.00M – $98.00M–NewNov 5, 2026
adjusted EBITDAnon-GAAPFY2026$92.00M – $99.00M$100.00M – $107.00MLoweredAug 6, 2026
adjusted EBITDA growthnon-GAAPFY2026+12% – +20%+18% – +22%LoweredMay 7, 2026

Guidance vs results

The last range Artivion gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$439.00M – $445.00M$441.40MΣ4QWithin range

Guidance history

Every forecast Artivion put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026adjusted EBITDAFY2026$93.00M – $98.00MNew
Nov 5, 2026growth on an adjusted constant currency basisFY2026+8% – +10%New
Nov 5, 2026revenueFY2026$484.00M – $492.00MNew
Aug 6, 2026adjusted EBITDAFY2026$92.00M – $99.00MLowered
Aug 6, 2026revenue growthFY2026+7% – +11%Reaffirmed
Aug 6, 2026revenueFY2026$480.00M – $496.00MReaffirmed
May 7, 2026adjusted EBITDA growthFY2026+12% – +20%Lowered
May 7, 2026adjusted EBITDAFY2026$100.00M – $107.00MLowered
May 7, 2026revenue growth on an adjusted constant currency basisFY2026+7% – +11%Lowered
May 7, 2026revenueFY2026$480.00M – $496.00MLowered
Feb 12, 2026adjusted EBITDA growthFY2026+18% – +22%New
Feb 12, 2026adjusted EBITDAFY2026$105.00M – $110.00MNew
Feb 12, 2026growth on an adjusted constant currency basisFY2026+10% – +14%New
Feb 12, 2026revenuesFY2026$486.00M – $504.00MNew
Nov 6, 2025adjusted EBITDAFY2025$88.00M – $91.00MNew
Nov 6, 2025constant currency growthFY2025+13% – +14%New
Nov 6, 2025reported revenuesFY2025$439.00M – $445.00MNew
Aug 7, 2025adjusted EBITDA growthFY2025+21% – +28%Raised
Aug 7, 2025adjusted EBITDAFY2025$86.00M – $91.00MRaised
Aug 7, 2025constant currency growthFY2025+12% – +14%Raised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Artivion filed with the SEC as exhibits to Form 8-K or 6-K

  1. Artivion Reports Third Quarter 2026 Financial Results
    Results
  2. Artivion Reports Second Quarter 2026 Financial Results
    Results
  3. Artivion Completes Acquisition of Endospan Ltd.
    Update
  4. Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
    Results
  5. Brian Johnston / Laine Morgan
    Results
  6. Artivion Reports Third Quarter 2025 Financial Results
    Results
  7. Brian Johnston / Laine Morgan
    Results
  8. Brian Johnston / Laine Morgan
    News
  9. Brian Johnston / Laine Morgan
    News
  10. Brian Johnston / Laine Morgan
    Results
  11. Brian Johnston / Laine Morgan
    Results
  12. Brian Johnston / Laine Morgan
    News
  13. Brian Johnston / Laine Morgan
    Results
  14. Brian Johnston / Laine Morgan
    Results
  15. Brian Johnston / Laine Morgan
    Update

See a number that looks wrong?